Device type · DSY
Prosthesis, Vascular Graft, Of 6mm And Greater Diameter
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
DSY
Cardiovascular
Device class
Class II
FDA decisions since 2015
22
510(k), De Novo and PMA
Adverse event reports
253
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Prosthesis, Vascular Graft, Of 6mm And Greater Diameter
- Product code
- DSY
- Device class
- Class II
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.3450
- Specialty
- Cardiology
- FDA record
- Classification database entry for DSY
Latest FDA decisions
The 8 newest of 22 since 2015.
K252445 · Decided Apr 27, 2026 · 266 days after receipt
Device type: Prosthesis, Vascular Graft, Of 6mm And Greater Diameter (DSY) · Cardiology
Vascular Flow Technologies Limited
K252277 · Decided Oct 20, 2025 · 90 days after receipt
Device type: Prosthesis, Vascular Graft, Of 6mm And Greater Diameter (DSY) · Cardiology
K241550 · Decided Feb 27, 2025 · 272 days after receipt
Device type: Prosthesis, Vascular Graft, Of 6mm And Greater Diameter (DSY) · Cardiology
19 more FDA decisions with a free account
Reports received
253
Received Nov 1, 2025 to Nov 19, 2026. Includes 1 of another or unstated type.
Malfunction reports
70
28% of reports
Injury reports
175
69% of reports
Death reports
7
2.8% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 2 | 3 | 0 | 0 |
| Jan 24 | 5 | 5 | 0 | 0 |
| Feb 24 | 6 | 18 | 1 | 0 |
| Mar 24 | 5 | 7 | 2 | 0 |
| Apr 24 | 6 | 17 | 0 | 0 |
| May 24 | 5 | 6 | 1 | 0 |
| Jun 24 | 6 | 14 | 0 | 0 |
| Jul 24 | 4 | 10 | 0 | 0 |
| Aug 24 | 3 | 6 | 0 | 0 |
| Sep 24 | 1 | 3 | 0 | 0 |
| Oct 24 | 6 | 1 | 0 | 0 |
| Nov 24 | 4 | 5 | 0 | 0 |
| Dec 24 | 5 | 2 | 1 | 0 |
| Jan 25 | 5 | 19 | 3 | 0 |
| Feb 25 | 0 | 4 | 1 | 0 |
| Mar 25 | 4 | 5 | 0 | 0 |
| Apr 25 | 2 | 7 | 0 | 0 |
| May 25 | 6 | 25 | 0 | 0 |
| Jun 25 | 3 | 10 | 0 | 0 |
| Jul 25 | 3 | 15 | 1 | 0 |
| Aug 25 | 3 | 1 | 0 | 0 |
| Sep 25 | 0 | 9 | 0 | 0 |
| Oct 25 | 5 | 14 | 0 | 0 |
| Nov 25 | 3 | 12 | 0 | 0 |
| Dec 25 | 0 | 7 | 0 | 0 |
| Jan 26 | 1 | 6 | 1 | 0 |
| Feb 26 | 1 | 5 | 0 | 0 |
| Mar 26 | 17 | 15 | 0 | 0 |
| Apr 26 | 11 | 19 | 0 | 0 |
| May 26 | 6 | 20 | 1 | 0 |
| Jun 26 | 0 | 12 | 0 | 0 |
| Jul 26 | 4 | 17 | 1 | 0 |
| Aug 26 | 11 | 11 | 0 | 0 |
| Sep 26 | 9 | 26 | 1 | 0 |
| Oct 26 | 7 | 25 | 3 | 1 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
5 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem75
- Obstruction of Flow34
- Peeled/Delaminated26
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions70
- Thrombosis/Thrombus59
- Obstruction/Occlusion44
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-3258-2026 · Started Aug 12, 2026 · Posted by FDA Sep 23, 2026
Reason given: Product failed to meet the specified acceptance criteria for Integral Water Permeability (IWP).
Cause as FDA categorized it: Under Investigation by firm
Z-1492-2026 · Started Dec 18, 2025 · Posted by FDA Mar 4, 2026
Reason given: Gelatin sealed woven polyester prostheses devices, designed for vascular repair, were incorrectly labeled with an additional month of shelf life. Device expiry should have been calculated from gel impregnation (date of manufacture) but it was incorrectly calculated from device packaging.
Cause as FDA categorized it: Error in labeling
Z-0036-2026 · Started Aug 26, 2025 · Posted by FDA Oct 2, 2025
Reason given: Reports of vascular graft delamination, which may lead to reduced access flow; cannulation difficulties; bleeding or bruising; and harms related to reintervention procedures, so Instructions for Use will be updated to modify existing warning to 1) further clarify techniques that may contribute to the risk of...
Cause as FDA categorized it: Unknown/Undetermined by firm
84 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.